SUMMARY.-Albumin distributions and turnover rates have been studied using 131I labelled tracer material in rabbits with Vx2 carcinoma and rats bearing SP7 fibrosarcoma in comparison with control animals. Albumin concentrations were reduced in the tumour bearing animals but plasma volumes increased as the tumours developed. Relative increases were seen in the extravascular distribution of albumin, due partly to albumin pooling in and around the tumours and possibly also to general increases in capillary permeability. In the rats there was a considerable increase in the catabolic rate of albumin which was not related to urinary protein loss. The tumour bearing rabbits showed evidence both of increased catabolism and of decreased synthesis and the combination of the two effects resulted in a greater lowering of albumin concentration than was seen in the rats. Possible mechanisms for these findings and their significance in human malignant disease are discussed.
ALBUMIN METABOLISM IN RABBITS AND RATS WITH TRANSPLANTED TUMOURS E. P. WRAIGHT
From the Department of Radiotherapeutics, The University, Crmbridge
Received for publication April 5, 1971 SUMMARY.-Albumin distributions and turnover rates have been studied using 131I labelled tracer material in rabbits with Vx2 carcinoma and rats bearing SP7 fibrosarcoma in comparison with control animals. Albumin concentrations were reduced in the tumour bearing animals but plasma volumes increased as the tumours developed. Relative increases were seen in the extravascular distribution of albumin, due partly to albumin pooling in and around the tumours and possibly also to general increases in capillary permeability. In the rats there was a considerable increase in the catabolic rate of albumin which was not related to urinary protein loss. The tumour bearing rabbits showed evidence both of increased catabolism and of decreased synthesis and the combination of the two effects resulted in a greater lowering of albumin concentration than was seen in the rats. Possible mechanisms for these findings and their significance in human malignant disease are discussed.
A NUMBER of albumin turnover studies have been earried out in cancer patients (Steinfeld, 1960; Waldman et al., 1963; Wetterfors etal., 1962; Jarnum and Schwartz, 1960; Cohn et al., 1966; Sum et al., 1964) to try to elucidate the causes of the hypoalbuminaemia which often accompanies malignant disease (Mider et al., 1950) . External protein leakage, decreased synthesis, increased catabolism and additional extravascular albumin pools have all been reported. The impossibility of obtaining a well-defined homogeneous group of subjects with malignant disease and the difficulty of defining a valid grodp of controls for comparative measurements probably contribute to discrepancies between the various reports.
Studies in tumour bearing animals can avoid these particular problems. Norberg and Greenberg (1951), using mice, and Hradec (1958) , using rats, studied the rate of uptake of labelled amino-acids by plasma proteins in tumour bearing animals. Babson (1956) and Hradec (1958) measuredthe slope oftheintravascular retention curve after injecting labelled albumin into rats with Walker carcinomas. All these studies suggested that plasma protein turnover rates are increased by the presence oftumours. However, the interpretation ofthe uptake studies is uncertain because of differences in competition for amino-acids from other tissues. The other studies did not examine the turnover kinetics in any detail nor did they differentiate between loss of tracer from the circulation by equilibration with extravascular albumin, and loss by catabolism. In addition Dinh and Brassard (1968) have shown greatly increased renal protein losses in rats with Walker carcinomas.
The present work was carried out to investigate the turnover and the distribution of albumin in rabbits implanted with Vx2 carcinoma (experiments A and B) and in rats bearing SP7 fibrosarcoma (experiment C).
METHODS
Twelve male New Zealand White rabbits, initially weighing 3 to 31 kg., were used in experiment A and 24 similar rabbits, weighing 2 2 to 3 kg. initially, in experiment B. Vx2 carcinoma was implanted in both experiments by injection of minced tumour into the right thigh muscle. The SP7 fibrosarcoma used in experiment C was a relatively non-antigenic tumour (Embleton, 1968) (Webster, 1965) .
The fraction of injected dose remaining in the body was measured daily using a clinical whole body counter. Each animal was counted in turn in a box midway between two 6 inch x 4 inch scintillation crystals, a standard again being used to correct for decay and systematic errors. The first measurement was made immediately after injection and this was taken as the 100% value with which subsequent daily counts were compared. The extravascular fraction of the injected activity at different times was found by subtracting the intravascular retention from the whole body retention. A typical example of the results from one of the rabbits is shown in Fig. 1 .
Fractional catabolic rates (F.C.R.) were calculated by the urinary excretion/ plasma activity (U/P) method of Campbell et al. (1956) . No correction was made for the effect of blood sampling which amounted to about 4% of the F.C.R. in rabbits and 6% in rats. The compartment analysis method of Matthews (1957) was not valid in the tumour-bearing animals because divergence of the logarithmic plots of whole body and plasma activity retention showed that a steady state situation did not exist. The divergence could not be explained in terms ofretention of activity in fur because the curves were parallel in the control animals. The U/P method is still valid in theory, even in the non-steady state, if catabolism occurs in metabolic equilibrium with the intravascular pool. However, it gives inflated values for F.C.R. if the clearance of iodide from the body is not much more rapid than albumin breakdown (Matthews, 1966) . In the rabbits results by the U/P method agreed very closely withthe results by more sophisticated methods (Wraight, 1969a) . Comparison with the results of Matthew's method in the control rats gave results that were consistently high by a factor of 1 2. Analogue computer simulation of the non-steady state situation suggested that the results by the U/P method in the tumour bearing rats were also high by about the same factor. Corrected values of F.C.R. and catabolic rate are therefore included in Table IV together with the original U/P values.
In the absence of steady state conditions, synthesis rates could not be determined from catabolic rates directly. However, in experiment B the total exchangeable albumin was measured at the beginning and the end of the experiment and it was therefore possible from the catabolic rate to estimate the rate of synthesis.
The extravascular/intravascular albumin pool ratio (EV/IV ratio) was calculated by the equilibrium time method (Campbell et al., 1956 ). This often involves considerable error in practice due to the difficulty of determining the exact point of maximum of the extravascular retention curve. This error was minimized by fitting the whole body and plasma retention data by multiexponential expressions derived by a " least squares " computer procedure and differentiating the algebraic difference to find the exact point of maximum. Fairly good agreement of results with the motre sophisticated method of Matthews (1957) was found in the control rabbits (Wraight, 1969a) and rats.
Np
The fractional rate of transfer of albumin out of the circulation was found by deconvolutional analysis (Vitek et at., 1966; Wraight, 1969a) .
The rat albumin used for labelling was isolated from pooled serum by ammonium sulphate fractionation followed by dialysis. Crystalline rabbit albumin separated by Cohn fractionation (Koch Light, Ltd) was used in the rabbit experiments. In experiment B the labelled albumin was screened by injection into another rabbit. This was bled 48 hours later and the serum separated for injection. The validity of the labelled albumin as a metabolic tracer was checked by the following criteria:
(1) There was no excess excretion of activity in the first 48 hours after injection. (2) There was no change in the plasma rate constant with time in the control animals. (3) The mean F.C.R. in control animals was in good agreement with previously reported values in rabbits (Reeve and Roberts, 1959; Matthews, 1965) and in rats (Matthews, 1957) . In rabbits mean results on four occasions were 025, 021, 026 and 0225 calculated both by the U/P method and by compartmental analysis. In rats the mean value by compartmental analysis was 078.
However, the plasma curves were very steep initially in experiment A and this may have indicated some contamination of the tracer material with small amounts of haemoglobin or denatured albumin. The calculated fractional transfer rates were therefore corrected as previously described (Wraight, 1969a) . No such anomalies were detected using the screened material in experiment B. Twenty-four hours after the final injection of labelled albumin in experiment A the total body activity was measured in three rabbits and, after dissection, the activity in the tumours was also measured. The animals and tumours were also weighed. The tumours contained 11.4%, 12-4% and 15.8% of the total body activity and this represented concentration of activity by factors of 1 80, 2-16 and 2*99 respectively, relative to the mean distribution in the body as a whole.
In experiment C, 24 hour urine collections were made at intervals in two tumour bearing rats and two controls. Protein concentrations were measured by a Folin technique after precipitation with trichloracetic acid. Daily urinary protein excretion was the same in tumour bearing animals as in controls and showed no change with tumour growth.
RESULTS
The mean values of the various turnover parameters measured in the tumour bearing and control groups of animals in the three experiments are given in Tables I to IV. Fig. 2 shows the way the mean albumin concentrations and mean plasma volumes in the tumour bearing animals varied during tumour growth in rabbits, expressed in each case relative to the corresponding values in the control animals.
In experiment B there was a mean net decrease in total exchangeable albumin of 1-29 g., in the tumour bearing animals compared with a mean increase of 032 g., in the controls (P <0 05). The estimated mean synthesis rates were 0-96 g./day (0-356 g./kg. body wt/day) in the tumour bearing animals and 1-04 g./day (0-378 g./kg. body wt/day) in the controls. These differences were not statistically significant. In all three experiments both the serum albumin coincentration and the intravascular albumin mass were significantly decreased in the tumour bearing animals. The probable causes of these changes are of interest not only in relation to the particular tumours studied but also because of the light they throw on possible mechanisms in human malignant disease.
The effect of tumours on plasma volume A tendency for plasma volume to be increased in cancer patients is suggested by a number of studies (Bateman, 1951; Kelly et al., 1952; Berlin et al., 1955; Peden et al., 1960; Blakeley et al., 1962; Banerjee and Narang, 1967) . However, these findings were not confirmed by Reeve et al. (1968) . Peden et al. (1960) showed that the amount of body fat was a significant factor and that quite high plasma volumes per unit body weight were found in cases of non malignant cachexia.
The main problem in assessing plasma volume determinations in cancer patients is to decide what are the expected normal values for the patients in question. A number of prediction formulae based on weight and height have been derived from regression analysis of data from normal subjects (Nadler et al., 1962) , but these are not necessarily valid in disease situations. Animal studies offer the advantages of serial measurement during tumour growth in addition to ease of comparison with normal controls.
In the rats and rabbits there was a significant increase in plasma volume in the tumour bearing animals. The change in plasma volume per unit body weight occurred earlier than the absolute volume increase in experiments B and C and roughly coincided with the first decreases in weight (see Fig. 2 ). Thus an early effect of tumour growth was a diminution in body weight, without a corresponding reduction in plasma volume. However there was an increase in absolute plasma volume in addition to an apparent effect due to cachexia. This occurred a little later in tumour development after other effects such as decreased serum albumin concentration had occurred.
The mechanism of this effect is obscure. Hormnonal changes secondary to the tumour growth may be responsible. Alternatively the volume change could be secondary to the decrease in albumin concentration. Increased plasma volume is seen after plasmapheresis in man and in rabbits (Matthews, 1965) . Increases have also been reported in a number of clinical conditions in which serum albumin concentration is decreased such as malnutrition (Picou and Waterlow, 1962) , cirrhosis (Dykes, 1968) and nephrotic syndrome (Jensen et al., 1967) , although other factors may play a part in these cases. In none of the present studies was there a significant correlation between albumin concentration and plasma volume, so if a direct relationship did exist it was obscured by other factors.
There is also the further possibility that if a tumour can itself cause an increase in plasma volume, the resulting plasma dilution might be one of the factors contributing to the hypoalbuminaemia of malignancy. The lack of correlation between albumin concentration and plasma volume is evidence against this view also.
Albumin distribution ratio
Even at the start of the turnover studies in the rats when the tumours were quite small the EV/IV ratio was possiby increased (0)05 <P <0 1) and analogue simulation suggested that the increase became greater with the growth of the tumours. In experiment A and following the second injection in experiment B, the EV/IV ratio was significantly raised in the tumour bearing rabbits (Tables I and  III) . To some extent this was due to pooling of albumin in and around the tumours as the measurements suggested that up to 15% of the total exchangeable albumin in the body may be located in a large tumour. Similar pooling at wound sites has been shown to cause hypoalbuminaemia in patients following operations (Mouridsen, 1967) . Generalized increases in capillary permeability may also contribute to the change in the distribution ratio. The fractional transfer rate between intravascular and extravascular pools was significantly raised in tumour bearing animals in experiment A, although no such effect was observed in experiment B. Corradi et al. (1968) have reported increases in overall capillary permeability in cancer patients. This may be a contributory factor in some cases of oedema associated with malignant disease. The mechanism of such changes is not clear.
The importance of such a redistribution of albumin in lowering the plasma concentration probably depends on the ratio of the F.C.R. to the fractional transfer rate. The effect is likely to be small in rats where the F.C.R. is relatively high but is probably appreciable in rabbits and it could make a significant contribution in man.
Albumin synthesis and catabolism Matthews (1966) has shown that the higher the F.C.R., the greater is its overestimation by the U/P method. It is therefore probable that even the corrected results for catabolism are too high in the tumour bearing rats. Nevertheless, it is certain that the catabolic rate is increased considerably above normal in the presence of the SP7 fibrosarcoma. However, it seems likely that the decrease in intravascular albumin during experiment C is balanced to some extent by the increase in EV/IV ratio and that the total exchangeable albumin remains much the same. Thus the synthesis is probably increased nearly as much as catabolism. There is certainly no evidence of any depression of the synthetic process. It may be that the reason why there is only a small decrease in albumin concentration is that increased synthesis is able to compensate almost entirely for the large increase in catabolism. In this respect the SP7 fibrosarcoma probably differs from the Walker carcinoma, as Toporek (1969) (Sterling, 1960 , and Grossman et al., 1960 ), dogs (Takeda, 1964 and rabbits (Rothschild et al., 1958) , and increased adrenal activity has been noted both in tumour bearing animals (Begg, 1958; Kavetsky et al., 1962) and in cancer patients (Licter and Sirett, 1968; Werk and Sholiton, 1960) . Alter- natively it has been suggested (Busch, 1962 ) that tumours take up and catabolize albumin as a source of amino-acids. The rate at which this occurs has not been measured experimentally but Gullino (1966) has suggested on the basis of blood flow studies that some tumours derive most of their protien from this source. The effect of this on total catabolic rate will be greater if cell loss from tumours occurs to the extent suggested by Refsum and Berdal (1967) . Decreased synthesis could in theory be the result of restriction of the aminoacids available to the liver, either due to competition with the tumour or to diminished protein intake. However, serum amino-acid concentrations tend to be raised in tumour bearing animals and cancer patients (Henderson and Le Page, 1959) . A specific humoral inhibition of albumin synthesis is suggested by liver perfusion studies in rats (Toporek, 1969) in which the synthesis rate was significantly lowered when livers from normal rats were perfused with blood from rats bearing Walker carcinomas.
Decreases in albumin concentration can potentially be minimized either by increased albumin synthesis or by reduced catabolism. Increased syntlhesis is observed after plasmapheresis in rabbits (Matthews, 1965) and in many cases of nephrotic syndrome (Jensen et al., 1967) . Decreased catabolism occurs in cirrhosis of the liver (Dykes et al., 1966) . When the pathological process affects both synthesis and catabolism, as in experiments A and B, such compensation is much more difficult and the albumin concentration is depressed to a greater extent than if one process or the other alone were altered. Conversely a relatively small patlhological change in both synthesis and catabolism may produce a significant reduction in albumin concentration. Measurements in nine patients with cancer in whom there was a marked reduction in serum albumin (Wraight, 1 969b) revealed no statistically significant differences from controls in either synthesis or catabolism. It seems likely that malignant disease can affect both processes and that the relative importance of each effect varies with the type of tumour and its size and degree of spread in the body. Both increased catabolism (Sum et al., 1964; Cohn et al., 1966) and decreased synthesis (Steinfeld, 1960; Waldman et al., 1963) have been reported previously in studies on patients with malignant disease.
